Karyopharm Therapeutics Inc. ($KPTI)
Poulton Stuart โ EVP, Chief Development Officer
Shares
378
Price
$8.63
Total Value
$3,262.14
Nearby Earnings
Feb 12, 2026
EPS:Est: -2.26
Revenue:Est: $33.16M
Feb 18, 2026
EPS:Est: -2.26
Revenue:Est: $33.16M
Transaction Details
| Insider | Poulton Stuart |
|---|---|
| Title | EVP, Chief Development Officer |
| Transaction Date | Feb 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Sold | 378 |
| Price per Share | $8.63 |
| Total Value | $3,262.14 |
| Shares Owned After | 99,429 |
| Derivative | No |
| Accession Number | 0001193125-26-059332 |
| Document | View SEC Filing |